Does PALBOCICLIB Cause Clostridium difficile infection? 78 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 78 reports of Clostridium difficile infection have been filed in association with PALBOCICLIB (Ibrance). This represents 0.1% of all adverse event reports for PALBOCICLIB.
78
Reports of Clostridium difficile infection with PALBOCICLIB
0.1%
of all PALBOCICLIB reports
9
Deaths
42
Hospitalizations
How Dangerous Is Clostridium difficile infection From PALBOCICLIB?
Of the 78 reports, 9 (11.5%) resulted in death, 42 (53.8%) required hospitalization.
Is Clostridium difficile infection Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for PALBOCICLIB. However, 78 reports have been filed with the FAERS database.
What Other Side Effects Does PALBOCICLIB Cause?
Fatigue (15,190)
White blood cell count decreased (11,273)
Neoplasm progression (10,885)
Death (8,410)
Nausea (8,189)
Neutropenia (6,423)
Alopecia (6,201)
Diarrhoea (5,635)
Asthenia (3,660)
Off label use (3,405)
What Other Drugs Cause Clostridium difficile infection?
ADALIMUMAB (1,502)
INFLIXIMAB (1,419)
VEDOLIZUMAB (1,130)
LENALIDOMIDE (814)
VANCOMYCIN (743)
METRONIDAZOLE (619)
PREDNISONE (618)
METHOTREXATE (588)
RITUXIMAB (532)
CIPROFLOXACIN (508)
Which PALBOCICLIB Alternatives Have Lower Clostridium difficile infection Risk?
PALBOCICLIB vs PALIPERIDONE
PALBOCICLIB vs PALIVIZUMAB
PALBOCICLIB vs PALONOSETRON
PALBOCICLIB vs PAMIDRONATE
PALBOCICLIB vs PAMIDRONIC ACID